Skip to main content
Medrx Co.,Ltd. logo

Medrx Co.,Ltd. — Investor Relations & Filings

Ticker · 4586 ISIN · JP3921220004 T Manufacturing
Open in API
Filings indexed 77 across all filing types
Latest filing 2026-03-19 Regulatory Filings
Country JP Japan
Listing T 4586

About Medrx Co.,Ltd.

https://www.medrx.co.jp/english/

Medrx Co., Ltd. is a pharmaceutical formulation development company that specializes in creating new dosage forms of medicines. The company's core focus is its transdermal absorption technology, which is used to develop innovative drug delivery systems like patches. These products are designed to improve patient health and quality of life (QOL) by providing alternatives for medications that are difficult to administer orally or by helping to prevent patients from forgetting to take their medicine. Medrx is actively engaged in research and development, managing a pipeline of pharmaceutical candidates that utilize its proprietary formulation technologies.

Recent filings

Filing Released Lang Actions
確認書
Regulatory Filings Classification · 95% confidence The document is a 'Confirmation Letter' (Kakunin-sho) filed under the Financial Instruments and Exchange Act of Japan. It confirms the accuracy of the contents of the Annual Securities Report (Yuuka Shouken Houkokusho) for the fiscal year ending December 31, 2025. Since this is a formal regulatory filing required by law to accompany the annual report and does not fit into the other specific categories like 10-K or IR, it is classified as a Regulatory Filing.
2026-03-19 Japanese
有価証券報告書－第24期(2025/01/01－2025/12/31)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the standard annual financial report filed with the Financial Services Agency (FSA) in Japan. It contains comprehensive financial statements, management discussion, and business information for the fiscal year ending December 31, 2025. This corresponds to the 10-K equivalent in the Japanese regulatory framework. FY 2025
2026-03-19 Japanese
確認書
Regulatory Filings Classification · 100% confidence The document is a 'Confirmation Letter' (確認書) filed under the Financial Instruments and Exchange Act. It serves as an officer certification confirming the accuracy of a previously filed semi-annual report. According to the 'CERTIFICATION RULE', documents that are primarily officer certifications or attestations should be classified as Regulatory Filings (RNS), even if they reference a specific report type like an interim/semi-annual report. H1 2025
2025-08-08 Japanese
半期報告書－第24期(2025/01/01－2025/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '半期報告書' (Semi-Annual Report) filed by Medrx Co., Ltd. with the Shikoku Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MDA), and business information for the interim period ending June 30, 2025. This fits the definition of an Interim/Quarterly Report (IR) as it provides comprehensive financial data and analysis for a period shorter than a full fiscal year. H1 2025
2025-08-08 Japanese
臨時報告書
Share Issue/Capital Change Classification · 100% confidence The document is titled '臨時報告書' (Extraordinary Report) and is submitted to the '四国財務局長' (Director of Shikoku Local Finance Bureau) on June 13, 2025. Section 1 explicitly states the reason for filing is to report the resolution made by the Board of Directors regarding the offering of stock acquisition rights (new warrants) to directors, officers, and employees, pursuant to Article 24-5, Paragraph 4 of the Financial Instruments and Exchange Act. The content details the specifics of these stock acquisition rights (issuance price, exercise price, exercise conditions, etc.). This structure and content strongly indicate a filing related to capital structure changes or financing activities, specifically the issuance of stock options/warrants. This aligns best with the 'Capital/Financing Update' category (CAP). Although it is a formal regulatory filing, 'CAP' is more specific than the general 'RNS' fallback.
2025-06-13 Japanese
内部統制報告書－第23期(2024/01/01－2024/12/31)
Governance Information Classification · 100% confidence The document explicitly states in the header section ("【提出書類】") that it is an "内部統制報告書" (Internal Control Report). It references the legal basis under the Financial Instruments and Exchange Act ("金融商品取引法第24条の４の４第１項") and discusses the framework, scope, criteria, and results of evaluating internal controls over financial reporting ("財務報告に係る内部統制"). This directly corresponds to the requirements for an Audit Report/Information filing, specifically concerning internal controls, which aligns best with the 'Audit Report / Information (AR)' definition, as it is a formal report on internal control effectiveness, distinct from a full Annual Report (10-K) or a simple Earnings Release (ER).
2025-03-31 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.